Results
1
1 companies
argenx
Market Cap: €47.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€752.00
7D
-1.0%
1Y
55.7%
